🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to characterize the safety and pharmacokinetic ...
Status
Completed
Location
Onc001 50414
Start Date
2020-07-09
Trial ID
NCT04393298
Treatments Being Tested
The purpose of this study is to verify the efficacy of mFOLFOX6 + panitumum...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-29
Trial ID
NCT02394795
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
To evaluate the efficacy and safety of immune checkpoint inhibitor-based co...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-03-01
Trial ID
NCT07446465
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of adjuvant hype...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2016-11
Trial ID
NCT02965248
This is a prospective randomized controlled Phase Ⅱ/Ⅲ Clinical study to eva...
Status
Not Yet Recruiting
Location
Medical Oncology,Sun Yat-sen University Cancer Center
Start Date
2025-06-01
Trial ID
NCT06959693
Treatments Being Tested
The purpose of this study is to investigate biomarkers which may be predict...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-05-29
Trial ID
NCT02394834
This randomized pilot phase II trial studies how well molecular phenotyping...
Status
Terminated
Location
Case Comprehensive Cancer Center
Start Date
2015-02
Trial ID
NCT02392377
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Status
Terminated
Location
Mayo Clinic Cancer Center
Start Date
2020-07-29
Trial ID
NCT04363801
Hepatocellular carcinoma (HCC) is the second commonest cause of cancer deat...
Status
Recruiting
Location
Nanjing Drum tower hospital
Start Date
2020-11-01
Trial ID
NCT04595864
Treatments Being Tested